FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
Tandem Diabetes (NASDAQ: TNDM) reported Q4 EPS of $0.16, which may not compare to the analyst estimate of $0.21. Revenue for the quarter came in at $210 million versus the consensus estimate of $198.39 million.
GUIDANCE:
Tandem Diabetes sees FY2022 revenue of $845-860 million, versus... More

